Biotechnology and pharmaceutical company
Judge
- Class members alleged the Roche Group-member mismanaged its $12 billion 401(k) plan by paying excessive recordkeeping fees and offering a suite of customized target date funds that underperformed competitors
- The settlement announced last November “preserves ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.